Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division

This image opens in the lightbox

News provided by

Vectorspace AI

22 Jun, 2021, 17:51 GMT

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, June 22, 2021 /PRNewswire/ -- As the new space race heats up, more humans will be traveling into space than ever before. Spaceflight causes many changes in human health. Humans cannot be sent into space without understanding how to protect and repair human DNA along with tissue regeneration while in space.

To understand stressors and develop countermeasures that can be used to protect and repair human DNA while in space, Vectorspace AI welcomes Mina J. Bissell, Ph.D., distinguished senior scientist (the highest rank bestowed at Lawrence Berkeley National Laboratory (LBNL)/DOE) in the Biological Systems and Engineering Division, to its Scientific Advisory Board (SAB). Dr. Bissell was previously head of the Biosciences division of LNBL for 14 years along with being the chair of the 200+ page report for the NASA Space Radiation Health Program study related to a mission to Mars.

Dr. Bissell is one of five recipients of the 2020 Canada Gairdner International Award, an annual honor given to scientists who have contributed to transformative human health research. She is Faculty of four Graduate Groups in UC Berkeley: Comparative Biochemistry, Endocrinology, Molecular Toxicology, and Bioengineering (UCSF/UCB joint program). She has challenged several established paradigms, and pioneered the field of tumor microenvironment. Using mammary gland and breast cancer her body of work has provided the foundation for the current recognition of the pivotal role that extracellular matrix (ECM) signaling plays in regulation of gene expression in both normal and malignant cells. Her laboratory pioneered the use of 3D organoids and techniques that allowed her to prove her signature phrase that after conception, "phenotype is dominant over genotype."

Vectorspace AI specializes in detecting hidden relationships in data via advanced networks of data engineering pipelines designed to generate datasets and visualizations applied to space biosciences and is a long time collaborator with the Bissell Lab at LBNL under U.S. government contract No. DE-AC02-05CH11231 along with the U.S. Navy's Space and Naval Warfare (SPAWAR) division.

Specifically, Vectorspace AI applies 'tip of the spear' unsupervised learning methods in AI/ML connected to NLP/NLU (Natural Language Processing/Understanding) biological language modeling to generate datasets used to create relationship networks between genes, proteins, diseases, micronutrients and drug compounds. Data engineering pipelines are one of the most important pillars underpinning accelerated scientific discovery.

Dr. Bissell will be advising on partnerships in space biosciences with companies and space agencies such as Virgin Galactic, SpaceX, Blue Origin, NASA Space Biosciences, ESA, JAXA and others with a focus on research related to 'dynamic reciprocity', the ECM (Extra cellularmatrix), TME (Tumor Microenvironment), exosomes, simulated microgravity, biomarkers, ocular, brain ECM, nutrigenomics, GCR (Galactic Cosmic Rays), HZE (High-energy and high-charge ions), Bragg peak and 'track' correlation analysis related to DNA repair pathways along with high/low LET (Linear Energy Transfer) radiation, telomere elongation/shortening, chromosomal translocations and dysregulated gene expression and additional multiomics research in connection to space biosciences.

Additional research includes analysis of key targets and key effects of particle damage correlated to type of particle and track including:

Targets:

  • DNA bases/genes
  • Carbohydrates
  • Proteins
  • Lipids
  • Mitochondria
  • Blood cells
  • Membrane receptors
  • Cell adhesion molecules
  • ECM
  • Immune cells
  • Stem cells
  • Endothelium
  • Exosomes

Effects:

  • Clustered DNA damage
  • Persistent mutations and chomosome aberrations
  • Reduced DNA and cellular repair
  • Drastic G M block and altered cell cycle kinetics
  • Enhanced cytokine activation
  • Tumorigenesis at high dose, high-LET or HZE
  • Apoptosis, autophagy, senescence, mitotic catastrophe, necrosis
  • Altered gene expression and differentiation
  • Changes in cell-cell comms and non-targeted effects
  • Changes in cell adhesion and motility
  • Changes in angiogensis

Specific applications in space biosciences will benefit all humankind indefinitely while also leading to new discoveries and applications in precision and personalized medicine which can be applied today along with drug repurposing, repositioning, and discovery connected to healthspan and revenue.

Working with groups such as NASA's Human Research Roadmap (HRP), NASA GeneLab and Biospecimen Sharing Program (BSP), Vectorspace AI will apply advanced techniques in bioinformatics, AR/XR (Augmented/Extended Reality) and visualization to enable the generation and acceleration of new hypotheses and discoveries in space biosciences. Resulting practical applications in space biosciences can immediately translate into on-ground solutions in all of Life Sciences including licensing and royalty opportunities in the pharmaceutical industry. Future roadmaps include applications in nanomedicine and advanced materials connected to spaceflight.

Vectorspace AI continues to maintain applications in the financial and cryptocurrency markets that provide hedge funds, asset management companies, and other institutions with datasets that generate alpha through its utility token, VXV. The token provides data lineage, provenance, governance and security for its datasets, which are mission critical for any data engineering operation today. Datasets are accessed through the VXV wallet-enabled API.

About Vectorspace

Vectorspace AI  provides high value correlation matrix datasets to enable researchers with the ability to accelerate their data-driven innovation and discoveries using patent protected NLP/NLU. Clients save time in the research loop by quickly testing hypotheses and running experiments with higher throughput. Vectorspace AI originated in the Life Sciences dept. of Lawrence Berkeley National Laboratory (LBNL) where the founders developed the patents that drive the company's innovation for a variety of academic institutions including CERN. Visit https://vectorspace.ai

Logo - https://mma.prnewswire.com/media/1538773/vectorspace_ai_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.